{"acquisitions":[],"changes":[],"country":"US","description":"MapLight Therapeutics develops small-molecule treatments for neuropsychiatric and neurological conditions including autism-related social symptoms and schizophrenia. Patients with serious psychiatric disorders are the eventual customer base. MapLight pursues circuit-targeted mechanisms in partnership with academic neuroscience labs.","domain":"maplighttx.com","employees":null,"founded":2018,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":37.385391,"lng":-122.033657,"location":"Redwood City, CA","multiples":[],"name":"MapLight Therapeutics","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":372500000,"connectionsAmong":[],"currency":"USD","date":"2025-07-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"maplighttx-com-2025-07-01-series-b","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-26","status":"attributed","url":null},"status":"attributed","type":"series-d+","url":null}],"slug":"maplighttx-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-26","status":"attributed","url":null},{"fact":"existence","publisher":"maplighttx.com","retrievedAt":"2026-05-26","status":"self-reported","url":"https://maplighttx.com"},{"fact":"description","publisher":"maplighttx.com","retrievedAt":"2026-05-26","status":"self-reported","url":"https://maplighttx.com"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":[],"totalRaisedUsd":400000000,"traction":[],"updatedAt":"2026-05-26","valuations":[]}